Recombinant DLL3 (Rovalpituzumab Biosimilar) anticorps

N° du produit ABIN7581372

Cet anticorps Human Monoclonal détecte spécifiquement DLL3 (Rovalpituzumab Biosimilar) dans FACS, ELISA, BLI, Func et SPR. Il présente une réactivité envers Humain.

Aperçu rapide pour Recombinant DLL3 (Rovalpituzumab Biosimilar) anticorps (ABIN7581372)

Antigène: DLL3 (Rovalpituzumab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Human

Clonalité: Monoclonal

Conjugué: Cet anticorp DLL3 (Rovalpituzumab Biosimilar) est non-conjugé

Application: Flow Cytometry (FACS), ELISA, Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Détail du produit anti-DLL3 (Rovalpituzumab Biosimilar) anticorps

Expression System: CHO Cells

Fonction: Anti-DLL3 Reference Antibody (rovalpituzumab)

Séquence: QVQLVQSGAE VKKPGASVKV SCKASGYTFT NYGMNWVRQA PGQGLEWMGW INTYTGEPTY ADDFKGRVTM TTDTSTSTAY MELRSLRSDD TAVYYCARIG DSSPSDYWGQ GTLVTVSSAS TKGPSVFPLA PSSKSTSGGT AALGCLVKDY FPEPVTVSWN SGALTSGVHT FPAVLQSSGL YSLSSVVTVP SSSLGTQTYI CNVNHKPSNT KVDKKVEPKS CDKTHTCPPC PAPELLGGPS VFLFPPKPKD TLMISRTPEV TCVVVDVSHE DPEVKFNWYV DGVEVHNAKT KPREEQYNST YRVVSVLTVL HQDWLNGKEY KCKVSNKALP APIEKTISKA KGQPREPQVY TLPPSRDELT KNQVSLTCLV KGFYPSDIAV EWESNGQPEN NYKTTPPVLD SDGSFFLYSK LTVDKSRWQQ GNVFSCSVMH EALHNHYTQK SLSLSPG,EIVMTQSPAT LSVSPGERAT LSCKASQSVS NDVVWYQQKP GQAPRLLIYY ASNRYTGIPA RFSGSGSGTE FTLTISSLQS EDFAVYYCQQ DYTSPWTFGQ GTKLEIKRTV AAPSVFIFPP SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC

Attributs du produit: Anti-DLL3 Reference Antibody (rovalpituzumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Pureté: >95 %

Isotype: IgG1

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Commentaires:

Therapeutic Agents by Target and Mechanism: DLL3 inhibitors

Conditions: Cancer Lung Cancer (advanced small cell)

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Stock: 4 °C,-80 °C

Stockage commentaire: +4°C,-80°C

Détails sur DLL3 (Rovalpituzumab Biosimilar)

Antigène: DLL3 (Rovalpituzumab Biosimilar)

Classe de substances: Biosimilar

Sujet: Synonyms: Delta Like Canonical Notch Ligand 3, D3

Poids moléculaire: 145.5 kDa

UniProt: Q9NYJ7